Endothelin-1 circulating levels increase in patients with orthotopic heart transplantation and in chronic therapy with cyclosporine

Minerva Cardioangiologica

Volumn 49, Issue 1, 2001, Pages 15-22

  Letizia, C ^a,b   De Biase, L ^b   Caliumi, C ^a   Verrelli, C ^a   Semeraro, R ^b   Subioli, S ^a   Cerci, S ^a   D'Erasmo, E ^a  

^a POLICLINICO UMBERTO I   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Endothelin 1; Heart transplantation; Hypertension

Indexed keywords

CYCLOSPORIN A; ENDOTHELIN 1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG BLOOD LEVEL; DRUG UTILIZATION; FEMALE; HEART TRANSPLANTATION; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; MALE; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ANALYSIS OF VARIANCE; CYCLOSPORINS; ENDOTHELIN-1; FEMALE; HEART TRANSPLANTATION; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; MALE; MIDDLE AGED; REGRESSION ANALYSIS;

EID: 0035048943     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Kahan BD. Cyclosporine. N Engl J Med 1989;321: 1725-38.
2. Porter GA, Bennet WM, Sheps SG, Cyclosporine-associated hypertension. Arch Intern Med 1990;150: 280-5.
3. Hardesty RL, Griffith BP, Debski RF, Bahnson HT. Experience with cyclosporine in cardiac transplantation. Transplant Proc. 1983;15(Suppl 1)1:2553-8.
4. Bellet M, Cabrol C, Sassano P, Leger P, Corvol P, Menard J. Systemic hypertension after cardiac transplantation: effect of cyclosporine on the renin-angiotensin-aldosterone system. Am J Cardiol 1985;56:927-31.
5. Roullet J-B, Xue M, Mc Carron DA, Holcomb S, Bennet WM. Vascular mechanism of cyclosporine-induced hypertension in the rat. J Clin Invest 1994;93: 2244-50.
6. Hosoda K, Nakao K, Arai H, Suga S, Ogawa Y, Mukoyama M. Cloning and expression of human endothelin-1 receptor cDNA. Febs lett 1991;287: 23-6.
7. Bobik A, Grooms, A, Millar JA, Mitchell A, Grinpukel S. Growth factor activity of endothelin on vascular smooth muscle cells. Am J Physiol 1990;258:c408-15.
8. Tippins JR, Antoniw JW, Maseri A. Endothelin-1 is a potent constrictor in conductive and resistive coronary arteries. J Cardiovasc Pharmacol 1989;13:s177-9.
9. Li J-S, Schiffrin EL. Chronic endothelin receptor antagonist treatment of young spontaneously hypertensive rats. J Hypertens 1995;13:647-52.
10. Li J-S, Knafo L, Turgeon A, Garcia R, Schiffrin EL. Effect of endothelin artagonist on blood pressure and vascular structure in renovascular hypertensive rats. Am J Physiol 1996;40:H88-93.
11. Letizia C, Cerci S, De Toma G, D'ambrosio C, De Ciocchis A, Coassin S et al. High plasma endothelin-1 levels in hypertensive patients with low renin essential hypertension. J Hum Hypertens 1997;11:447-51.
12. Shichiri M, Hirata Y, Ando K, Ohta K, Kimoto S, Inove A et al. Plasma endothelin levels in hypertension and chronic renal failure. Hypertension 1990;15:493-6.
13. Letizia C, De Toma G, Cerci S, Scuro L, De Ciocchis A, D'ambrosio C et al. Plasma endothelin-1 levels in patients with aldosterone producing adenoma and pheochromocytoma. Clin Exp Hypertension 1996;18(7): 921-31.
14. Letizia C, Cerci S, Subioli S, Scuro L, Clemente G. Increased plasma endothelin-1 after nicotine consumption in non-smokers. Clin Chem 1997;43(12): 2440-1.
15. Letizia C, Barillà F, Cerci S, D'ambrosio C, Coassin S, De Ciocchis A et al. Dynamic exercise induces elevation of plasma levels of endothelin-1 in patients with coronary artery disease. Angiology 1995;46:819-23.
16. Chapman JR, Marcen R, Arlas M, Raine AEG, Dunnil MS, Morris PJ. Hypertension after renal transplantation. Transplantation 1987;43:860-4.
17. Myers BD, Ross J, Newton L, Luetscher J, Perloth M. Cyclosporine-assodated chronic neprhopathy. N Engl J Med 1984;311:699-705.
18. Schuler S, Thomas D, Hetzer R. Cyclosporine-A related nephrotoxicity after cardiac transplantation: the role of plasma renin activity. Transplant Proc 1987;19(5): 3998-4001.
19. Mc Kenzie N, Neown P, Stiller C, Kostuk W, Campbell C, Keith F. Effects of cyclosporine on renal functions following orthotopic heart transplantation. Heart Transplant 1985;1:400-3.
20. Baxter CR, Duggin GC, Hall BM, Horvat JS, Tiller DJ. Stimolation of renin release from rat cortical slices by cyclosporine-A. Res Commun Chem Pathol Pharmacol 1984;43:417-23.
21. Siegel H, Ryffel B. Effect of cyclosporine on renin-angiotensin-aldosterone system. Lancet 1982;2: 1274.
22. Lerman A, Kubo SH, Tschumperlin LK, Burnett JC. Plasma endothelin concentrations in human with endstage heart failure and after heart transplantation. JACC 1992;20:849-53.
23. Haas GJ, Wooding-Scott M, Binkley PF, Myerowitz PD, Kelley R, Cody RS. Effects of successful cardiac transplantation on plasma endothelin. Am J Cardiol 1993;71:237-40.
24. Rodeeffer RJ, Heublein DM, Mc Kinley L, Burnett JC Jr. Plasma endothelin concentrations are increased in humans with congestive heart failure. JACC 1991; 17(Suppl A):281A.
25. Takeda Y, Miyamori I, Yoneda T, Takeda R. Endothelin-1 release from mesenteric arteries of cyclosporine treated rats. Eur J Pharmacol 1992;213:445-7.
26. Pei Y, Chan C, Cattean D, Cardella C, Zartzman J, Lopez M et al. Sustained vasoconstriction associated with daily cyclosporine dose in heart and lung transplant recipients: potential pathophysiologic role of endothelin. J Lab Clin Med 1995;125:113-9.
27. Lerman A, Hildebrand PL, Aarhus LL, Burnett JC Jr. Endothelin has biological activity at pathophysiologic concentrations. Circulation 1991;83:1808-14.
28. Murali S, Vretsky BF, Reddy PS, Griffith BP, Hardesty RL, Trento A. Hemodynamic abnormalities following cardiac transplantation: relationship to hypertension and survival. Am Heart J 1989;118:334-41.
29. Fogo A, Hellings S, Inagami T, Kon V. Endothelin receptor antagonism is protective in vivo acute cyclosporine toxicity. Kidney Int 1992;42:770-2.